Abstract
The solubilization and partial purification from rat brain cortex homogenates of ["H]y-aminobutyric acid (GABA) and ["Hldiazepam recognition sites and of their endogenous modulators (GABAmodulin and an endogenous compound which displaces specifically bound ["Hldiazepam) are reported.
A high percentage of GABA binding sites (virtually free of benzodiazepine binding sites) was solubilized from homogenates of rat brain cortex incubated at 0°C with 1% Triton X-100 and a mixture of protease inhibitors. A large proportion of benzodiazepine binding sites was solubilized in the absence of apparent GABA binding capacity by incubating crude synaptic membrane preparations at 37°C with 0.05% Triton X-100. The characteristics of these two solubilized binding sites resemble those of the membrane-bound binding sites. However, unlike the membrane-bound sites, solubilized GABA and benzodiazepine recognition sites have lost the ability to cross-react. Hence, solubilized benzodiazepine binding sites are insensitive to GABA stimulation, while solubilized GABA binding sites are no longer protected by the benzodiazepines against heat inactivation. These results indicate that GABA and benzodiazepine recognition sites reside in two different molecules which, when bound to membranes, can interact reciprocally and modulate their binding affinity for specific ligands.
The recognition sites for benzodiazepines and y-aminobutyric acid (GABA) are located in the same postsynaptic membrane (Mohler et al., 1980a) and are coupled into a functional unit. In fact, GABA receptors function as a supramolecular entity, which includes the GABA recognition site, the benzodiazepine recognition site, and the Cll ionophore, in addition to a number of other unidentified components (Guidotti et al., 1977; Costa and Guidotti, 1979; Baraldi et al., 1979; Tallman et al., 1978 Tallman et al., , 1980 Sieghart and Karobath, 1980) . The benzodiazepine recognition site may be used physiologically by an endogenous agonist that participates in GABAergic transmission by modulating the affinity of the specific recognition sites for GABA (Guidotti et al., 1978; Skolnick et al., 1978; Asano and Spector, 1979; Colello et al., 1978; Davis and Cohen, 1980; Braestrup et al., 1980) . Such a close functional association between GABA and benzodiazepine binding sites is underscored by recent histological evidence showing the presence of benzodiazepine recognition sites vis-a-vis axon terminals containing glutamic acid decarboxylase (Mohler et al., 1980b) . This is in line with the observation made by Gavish and Snyder (1980) that GABA and benzodiazepine recognition sites can be solubilized as a functionally coupled unit. These results raise the question of whether GABA and benzodiazepine recognition sites are part of the same molecule or whether they are located in two distinct molecules functioning as an integral part of the same receptor. Since Gavish and Snyder (1980) solubilized only a portion of the membrane-bound GABA and benzodiazepine recognition sites, one might surmise that there are a number of functional arrangements for GABA and benzodiazepine receptors located in postsynaptic membranes and that the tight coupling is one of the ways in which these receptors are arranged. An understanding of this variability is crucial to define the molecular mechanisms whereby benzodiazepine recognition sites participate in the fine tuning of GABA receptors.
The present paper shows that it is possible to solubilize a major portion of GABA and benzodiazepine recognition sites as separate molecular entities. In addition, evidence is presented showing that each of the two sites is regulated selectively by an endogenous modulator protein.
Materials and Methods
Male Sprague-Dawley rats, 200 to 250 gm, were sacrificed by guillotine and the brain was removed immediately. The cortices were dissected rapidly according to the method of Glowinski and Iversen (1966) , placed on ice, and used as a source for the isolation and purification of ["Hlbenzodiazepine and ["HIGABA recognition sites. Massotti et al. Vol. 1, No. 4, Apr. 1981 Solubilization of [3H]benzodiazepine recognition sites The starting material was frozen-thawed crude synaptic membranes (CSM) (Enna and Snyder, 1977) , which were incubated at 0°C for 30 min in 20 vol of 50 mM Tris/ citrate buffer, pH 7.1, and then washed three times with the same buffer. This preparation was incubated at 37°C for 30 min in the presence of 0.05% Triton X-100. The suspension was then centrifuged at lo" x g for 1 hr at 4°C. Aliquots of 2 ml of the supernatant were filtered rapidly on a Sephadex G-100 minicolumn (2 x 8 cm) by centrifugation according to the method of Penefsky (1977) . The recovery of ["Hldiazepam binding sites throughout the column purification procedure was 75 + 9% (n = 3). The purified supernatants were pooled and lyophilized, and the number of solubilized high affinity binding sites for ["Hlbenzodiazepines was measured.
Solubilization of r3H]GABA recognition sites The cortices were homogenized with an Ultra Turrax homogenizer for 30 set in 20 vol (w/v) of 50 mM Tris/ citrate buffer, pH 7.1, containing 1% Triton X-100 (3.6 mg/lO mg of tissue), 1 mM EGTA (ethylene glycol bis(Paminoethyl ether)-N,N,N',N'-tetra-acetic acid), 1% pmercaptoethanol, 100 BAEE units/mg of protein of soybean trypsin inhibitor, 20 mM N-ethylmaleimide, 0.3 mM N-2-tosyl-1-lysin chloromethyl ketone. The homogenate was stirred at 4°C for 30 min and then centrifuged at lo" x g for 1 hr at 4°C. Aliquots of 2 ml of the 10' X g supernatant were filtered rapidly in succession, once on a Sephadex G-100 and twice on a Sephadex G-25 minicolumn (2 x 8 cm), using the method of Penefsky (1977) . In this supernatant, the recovery of ["HIGABA binding sites was approximately 70%. This purification procedure removes endogenous GABA, inhibitor of GABA binding, Triton X-100, protease inhibitors, and Tris/citrate. The final eluate, reconstituted in 50 mM Tris/citrate buffer, pH 7.1, was used in the binding studies. In this sample, ["HIGABA recognition sites were still in a soluble form because (a) they were not precipitated by centrifugation at 200,000 x g for 2 hr and (6) no binding of ["Hlmuscimol was detected if the sample was filtered through a 0.45-pm Millipore filter.
Solubilization
of GABA + benzodiazepine (BZD) recognition complex This complex was prepared according to the procedure described by Gavish and Snyder (1980) . Frozen-thawed CSM(s) incubated at 0°C in 50 IIIM Tris/citrate buffer (pH 7.1) for 30 min and then washed three times with the same buffer was used as a starting material for the preparation of the receptor complex. The final suspension was incubated at 0°C for 30 min in the presence of 1% Triton X-100 and then centrifuged at lo" x g for 1 hr. The supernatant was filtered by the rapid centrifugation method of Penefsky (1977) on a Sephadex G-100 column (2 x 8 cm). The resulting supernatant, which was termed "solubilized GABA. BZD recognition complex," was used in the binding studies.
Extraction
of "GABA-modulin" and of the endogenous inhibitor of specific f3H]benzodia.zepine recognition sites Frozen/thawed CSM(s) from cortex of rat brain was used as the starting material. Endogenous GABA and other amino acids that inhibit ["HIGABA binding were removed by incubating the CSM(s) at 37°C for 30 min in the presence of 0.05% Triton X-100 (0.18 mg/mg of membrane protein) and then washing the CSM(s) three times with 50 mM Tris/citrate buffer, pH 7.1 (Massotti and Guidotti, 1980) . GABA-modulin and the endogenous inhibitor of benzodiazepine binding were extracted by homogenizing these membranes in Hz0 (1 mg of protein/ ml of HZO) containing 0.05% Triton X-100. The suspension was incubated at 0°C for 30 min, sonicated for 30 set, and then centrifuged at 10" X g for 60 min. The operation was repeated a second time. The two 10" x g supernatants were lyophilized and, after reconstitution in H20, were termed "extract A" and used as a source for the preparation of either of the two inhibitors. Typically with this procedure, 12 pg of protein inhibitors are extracted from 1 mg of membrane proteins.
The inhibitor of [3H]benzodiazepine binding was isolated by incubating "extract A" for 15 min at 95°C and by chromatographing the 10" X g supernatant (20 min) with a Bio-Gel P-2 column (1 X 80 cm) and then with a Sephadex G-100 (1 X 80 cm) column equilibrated with 10 mM Tris/citrate buffer, pH 7.1. GABA-modulin was isolated from the 10" x g supernatant of fresh "extract A." One milliliter of this supernatant contained approximately 2.5 mg of protein, 2 mg of phospholipids, and 5 pmol of GABA. The sample was filtered five times by centrifugation on Bio-Gel P-2 (2 x 8 cm) (Mazzari et al., 1980) and then applied to a Sephadex G-50 column (1 x 80 cm) equilibrated with Tris/ citrate buffer, pH 7.1.
Determination
of GABA The GABA content of various preparations was determined using high pressure liquid chromatography (HPLC).
After 0.2 N perchloric acid extraction, the samples were processed according to Schmid et al. (1980) . GABA also was determined according to Bertilsson and Costa (1976) by ion monitoring (m/e 233 and 394) using a LKB 9000 gas chromatograph and mass spectrometer (GC-MS). The sensitivity was approximately 10 pmol for HPLC and 5 pmol for GC-MS.
Determination of phospholipids
The sample was extracted with 5 vol of chloroform/ methanol (2:l by volume) according to Folch et al. (1957) . The presence of phospholipids was examined on Silica Gel G thin layer chromatography using the method of Skipski and Barclay (1969) . After developing, the plates were dried and the phospholipids were visualized by exposure to iodine.
Studies on the thermolability of [3H]GABA recognition sites Suspensions of solubilized (300 to 400 pg of protein/ ml) or membrane-bound (800 to 1000 pg of protein/ml) recognition sites for ["HIGABA were preincubated at 4'C with lo-" M GABA (15 min), lo-" M diazepam, or other benzodiazepines
(1 hr). After incubation at 60°C for 1, 3, 6, 9, 12, and 24 min, the suspensions were cooled on ice.
In order to remove the GABA or the benzodiazepines from the solubilized recognition sites, these suspensions were filtered twice by centrifugation (Penefsky, 1977) on a Sephadex G-25 gel minicolumn.
To remove GABA or benzodiazepines from the membranes, the suspensions were centrifuged at 48,000 X g for 10 min and the pellets were washed twice with a double volume of 50 mM Tris buffer, pH 7.1. The following procedures were used to assay the high affinity binding of the different 3H ligands to soluble or membrane-bound specific recognition sites.
Solubilized GABA recognition sites. The reaction was initiated by adding 20 ~1 of the various ["HIGABA or ["Hlmuscimol solutions (to reach a final concentration of 0.3 to 240 nM in a total volume of 200 ~1) to a test tube containing solubilized recognition sites (40 to 60 pg of protein). After 5 min of incubation at 0°C the reaction was terminated by applying 50 ~1 of the incubation mixture on a minicolumn (0.5 x 6 cm) of Sephadex G-25 kept at 0°C. Bound ["HIGABA was separated from the free ["HIGABA by centrifuging the minicolumn at 1000 rpm for 2.5 min (Penefsky, 1977) . The radioactivity present in the first 50 ~1 of filtrate corresponded to the amount bound to the receptor. In the absence of protein, less than 0.5% of the radioactivity emerged in the void volume. Specific binding was calculated as the difference between the total binding and the binding that occurred in the presence of 1 mM GABA or 1 pM muscimol.
Solubilized benzodiazepine recognition sites. The reaction was initiated by adding 20 ~1 of the various ["Hldiazepam solutions (to reach final concentrations of 0.3 to 48 nM in a total volume of 200 ~1) to a test tube containing 40 to 60 pg of solubilized proteins. After 1 hr of incubation at 0°C the reaction was terminated by adding 200 ~1 of 0.1% y-globulin and 200 ~1 of 24% polyethylene glycol to precipitate the solubilized receptors as described by Yousufi et al. (1979) . The suspension was filtered immediately under a vacuum on a GF/B filter. The filter was washed with 9 ml of 50 InM Tris/citrate buffer, pH 7.1, containing 8% polyethylene glycol. In some experiments, the results obtained with the method of Yousufi et al. (1979) were repeated by terminating the reaction by filtration of the suspension on a Sephadex G-25 column (0.5 x 6 cm) according to Penefsky (1977) . No significant difference in the number of specific binding sites was found between the two methods used to terminate the reaction. Specific binding was calculated as the difference between the total binding and the binding that occurred in the presence of lo-" M diazepam or clonazepam.
Solubilized GABA. BZD recognition complex. [:'H]-GABA or ["Hldiazepam binding assays were performed as previously reported for the solubilized receptors.
Binding of ["HJGABA, ["H]muscimol, or ["Hldiazepam to the membrane-bound receptors. This binding was carried out with minor modifications of the method previously described (Baraldi et al., 1979) .
Statistical analysis The characteristics of ["H]GABA
and ["Hldiazepam binding were determined by using a Scatchard plot analysis of the saturation curves, Specifically, the Scatchard plots of the ["HIGABA binding data were prepared according to the graphic method of Rosenthal (1967) to determine the binding parameters (number of equivalent binding sites and the corresponding dissociation constants) in a complex system consisting of one ligand and two or more populations of binding sites. In each experiment, the values of the Ku and B,,, were between 5 and 10% of the mean Kn and B,,, values. The statistical significance of the results was determined by the Students t test (two tailed). Unbiased estimates of the standard error of the mean were computed and the means were compared as unpaired observations with equal variance.
Protein assay The protein concentration was measured by the method of Lowry et al. (1951) .
Results

Characterization
of the endogenous modulator of i3H]GABA
and t3H]diazepam binding. The inhibitor of ["HIGABA binding used in these experiments was isolated by Bio-Gel P-2 and Sephadex G-50 chromatography (see "Materials and Methods"). After Sephadex G-50, one major peak of inhibitory activity was obtained and this peak was eluted by a buffer volume similar to that of ribonuclease A. No significant inhibitory activity of ["HIGABA binding was eluted in the position in which r3H]GABA emerged. In a typical preparation, 100 ~1 of inhibitory peak (containing 10 pg of protein) produced a 50% inhibition of [3H]GABA binding. The characteristics of this inhibitor (GABA-modulin) are summarized in Table I .
A preliminary purification of the endogenous inhibitor of ["Hldiazepam binding was carried out by Bio-Gel P-2 column chromatography of a heat-treated brain extract (see "Materials and Methods"). This inhibitor emerged from this column with the void volume (see Fig. 1, upper) . When the effluent from the Bio-Gel P-2 column that contained this inhibitor was chromatographed with a Sephadex G-100 column, the major peak of inhibition emerged after the void volume and before ovalbumin (Fig. 1, lower) . The characteristics of the material endowed with the capacity to inhibit [3H]diazepam binding are summarized in Table I .
Solubilized preparation of benzodiazepine binding sites. The recognition sites for ["Hlbenzodiazepines which are located on CSM can be solubilized free from ["HIGABA binding capacity by treating frozen-thawed CSM (see "Materials and Methods") with 0.05% Triton X-100 at 37°C for 30 min. When this procedure is repeated three times and each time is followed by a CSM washing with Tris buffer, the number of ["Hldiazepam recognition sites that remain bound to the CSM decreases. In contrast, there is no apparent decrease in the number of Na+-independent, high or low affinity recognition sites for ["HIGABA (see Table II ). After each treatment, the decrease in the number of ["Hlbenzodiazepine binding sites located in CSM was paralleled by the appearance of an almost equal number of ["HIbenzodiazepine recognition sites in the 10" X g supernatant (Table III) . The solubilization of ["Hlbenzodiazepine binding sites occurred during the first and second incubation of the CSM with 0.05% Triton X-100; the third et al. The absence of apparent GABA binding sites was not due to the presence of contaminating GABA in the solubilized preparation because the content of GABA measured by HPLC and GC-MS techniques was below 1 pmol/assay tube (see also Table III ). Higher concentrations (up to 2%) of Triton X-100, Lubrol (0.576, 2 mg/mg of protein), or deoxycholate (2%, 10 mg/mg of protein) failed to solubilize the [3H]benzodiazepine binding sites that remained bound to CSM after two 0.05% Triton X-100 treatments.
However, each of these treatments produced the solubilization of a significant amount of GABA binding sites. When the solubilized material was applied to a Sephadex G-100 column (1 X 80 cm), approximately 90% of the solubilized recognition sites for [3H]benzodiazepine emerged from the column with the bulk of the (Fig. 3) , whereas these recognition sites, when they are bound to the membrane, like those that cannot be solubilized, have a KD of 8 nM and a B,,, of 1.4 pmol/ mg of protein. The solubilized binding sites are saturable (Fig. 3) , stereospecific (Fig. 4) , and have a Hill coefficient of 0.92. Moreover, the C3H]diazepam bound to solubilized recognition sites was displaced by various benzodiazepines with a rank order of potency similar to that displayed for r3H]diazepam bound to recognition sites located on CSM (see Fig. 4 ). The only exception was flunitrazepam which was more potent in displacing Figure 1 . Bio-Gel P-2 and Sephadex G-100 chromatography of the endogenous ligand of [3H]diazepam binding. The inhibitor was extracted from rat brain cortex as described under "Materials and Methods." Two milligrams of protein was applied to the Bio-Gel P-2 column. Fractions 11 to 18 were pooled, together lyophilized and resuspended in 1 ml of 50 mM Tris/ citrate, and applied to the Sephadex G-100 column equilibrated with the same buffer and 100 mM NaCl. Two hundred microliters of each fraction was used fo measure the inhibitory activity of ["Hldiazepam (1.5 nM) binding. Blue Dextran (DB), ovalbumin (OVA), and ,@mercaptoethanol (j?ME) were used as markers of the elution volume. S.B., specifically bound; O.D., optical density.
[3H]diazepam from solubilized than from membranebound recognition sites (Fig. 4) . Table IV shows that the binding of [3H]diazepam to solubilized recognition sites is no longer increased by the addition of GABA nor blocked by the addition of lop4 M bicuculline. This finding contrasts with the GABA-induced stimulation of [3H]-benzodiazepine binding to membrane-bound recognition sites or to solubilized GABASBZD recognition complex (see Table IV ). The endogenous compound that inhibits [3H]diazepam binding to specific recognition sites is equally potent in inhibiting the binding of [3H]benzodiazepines to membrane-bound recognition sites, to solubilized recognition sites complexed with GABA recognition sites, or to recognition sites that are solubilized without GABA binding sites (Table V) [3H]GABA recognition sites were purified and solubilized using as a starting material a homogenate of rat brain cortex. The [3H]GABA recognition sites were solubilized by homogenizing the tissue in a solution containing 1% Triton X-100 and a number of protease inhibitors (see "Materials and Methods"). The final concentration of GABA in this homogenate was about 5 X lo-" M. This extraction procedure solubilizes 72% of the GABA binding sites but only 8% of the benzodiazepine binding sites (see Table VI ). Concentrations of Triton X-100 higher than 1% failed to increase the extent of GABA binding site solubilization. Scatchard analysis of the Fig. 3 ). The KO of these two binding sites were similar to those described for [3H]GABA recognition sites located in CSM (Enna and Snyder 1977; Toffano et al., 1978) . The binding of C3H]GABA to solubilized recognition sites had the following characteristics:
1.
2.
3.
4.
5.
It was inhibited by bicuculline with an ICm of approximately 5 X lo-" M. It was inhibited by GABA-modulin with a potency similar to that observed in CSM or in solubilized GABA -BZD recognition complex (Table V) . The thermoinactivation characteristics of solubilized r3H]GABA binding sites were identical to those of the recognition sites bound to CSM (see Fig. 5 ). The rate of heat (60°C) inactivation of the solubilized GABA recognition sites was reduced when 10e5 M GABA was present in the incubation mixture (Fig. 5) . Diazepam, as well as other active benzodiazepines (flunitrazepam, clonazepam, RO 11 3128), but not the inactive RO 11 3624, prevented the heat inacti- The various benzodiazepines were added directly in the incubation mixture in concentrations (c) ranging from lo-" to 10-l' M. The dissociation constant used to calculate KI was 2.6 nM and 8.0 no for soluble and membranebound recognition sites, respectively. The SEM was less than 10% of the mean values. 6.
vation of ["HIGABA binding sites in CSM; however, these compounds failed to protect solubilized ["HIGABA recognition sites from heat inactivation (see Fig. 5 ).
The half-life of the solubilized GABA recognition sites was approximately 10 hr when the sample was maintained at 0 to 2°C.
Discussion
Previous reports in the literature have described the solubilization of GABA or benzodiazepine binding sites (Greenlee and Olsen, 1979; Yousufi et al., 1979; Asano and Ogasawara, 1980a, b; Gavish et al., 1979; Chude, 1979; Lang et al., 1979) . However, most of these studies failed to clarify whether the benzodiazepines and GABA receptors were extracted as a complex or as two separate subunits. In addition, in two studies (Yousufi et al., 1979 and Gavish and Snyder, 1980) in which the question of whether GABA and BZD binding sites can be solubilized as independent molecules has been addressed, the results reported appear to be discrepant. Yousufi et al. (1979) reported that the solubilization of benzodiazepine binding sites yields a preparation that is insensitive to GABA stimulation and, presumably, does not include GABA recognition sites; in contrast, Gavish and Snyder ( The basal values were 0.29 + 0.04 pmol/mg of protein and 0.41 pmol/mg of protein for membranebound and solubilized receptor sites, respectively. Each point is the mean of at least three experiments. The SEM was less than 10% of the mean values. S.B., specifically bound.
reported that GABA and benzodiazepine binding sites are solubilized as a complex because the addition of GABA increased the binding affinity of [3H]flunitrazepam by an extent similar to that observed when both recognition sites were bound to CSM.
We have been able to duplicate Gavish and Snyder's findings that GABA and benzodiazepine binding proteins can be solubilized as a complex (Guidotti et al., 1980 ; see also Table IV) . However, by modifying the extraction procedure, we can solubihze either benzodiazepine or GABA recognition sites practically devoid of the other binding site. The rationale for setting up the modification of Gavish and Snyder's procedure evolved from our studies on GABA and benzodiazepine binding using CSM.
When CSMs were incubated with 0.05% Triton X-109 at 37"C, the number of membrane-bound GABA recognition sites increased, while that of benzodiazepine binding sites was reduced (see also Table II) . Conversely, a treatment of CSM with 1 or 2% Triton X-100 significantly reduced the number of [3H]GABA binding sites present in CSM. Thus, the binding proteins for ["H] benzodiazepines, but not those for ["HIGABA, were solubilized by incubating at 37°C with 0.05% Triton X-100, frozenthawed, and repeatedly washed CSM prepared from rat brain cortex. The absence of [3H]GABA binding sites in this preparation of solubilized CSM proteins was proved both by the lack of high affinity binding sites for [3H]-muscimol and by the absence of ["Hldiazepam binding stimulation following the addition of GABA. We proved that, in this preparation, the lack of ["Hlmuscimol binding and that of GABA-induced stimulation of ["Hldiazepam binding was not due to the presence of GABA contamination. It is possible to suggest that the GABA receptors were extracted from CSM, but they were inactivated. We do not favor this hypothesis because we still find ["HIGABA binding sites in the membranes and when CSMs are extracted with higher concentrations of Triton X-100 (0.5 to l%), the number of ["HIGABA binding sites solubilized is equivalent to the number of binding sites lost from CSM. A maximal number of benzodiazepine recognition sites (approximately 50% of those located in CSM) was solubilized by incubating the CSM with 0.05% Triton X-100 for two successive times (Table III) . A third treatment of these CSMs with 0.05% or with 0.2, 0.5, 1, or 2% Triton X-100 failed to produce the solubilization of additional [3HJbenzodiazepine binding sites.
The characteristics of the solubilized ["Hlbenzodiazepine binding sites were similar to those of the sites located in CSM. They were stereospecific and the rank order of the ability of a series of benzodiazepines to displace ["Hldiazepam bound to these sites was similar to that to displace the ligand bound to recognition sites located in CSM. Actually, the affinity of the solubilized sites for ["Hldiazepam is 2 to 3 times higher than that of sites located in the intact CSM. A similar difference has been reported for binding sites where GABA.BZD recognition sites are solubilized as a functional complex (Guidotti et al., 1980) . GABA binding sites virtually free of benzodiazepine binding sites were solubilized by incubating homogenates of rat brain cortex at 0°C with 1% Triton X-100. From Table VI , it can be calculated that approximately 70% of the GABA recognition sites can be extracted using this procedure. The advantage of using crude brain homogenate as a starting material to prepare soluble GABA recognition sites is that of utilizing the protective action of large concentrations of endogenous GABA against the rapid degradation (peptidases?) of the specific binding site for the amino acid. The recovery of solubilized GABA recognition sites can be improved by supplementing the extraction buffer with a mixture of peptidase inhibitors to prevent the rapid degradation of the solubilized GABA recognition sites.
The solubilized GABA recognition sites, similar to those bound to CSM, include two populations of sites: a high (Ku = 30 nM) and a low (Ko = 280 nM) affinity site for ["HIGABA.
The binding of GABA to these sites is inhibited by bicuculline. However, unlike the GABA recognition sites located in CSM (Fig. 5) , the addition of benzodiazepines fails to protect the solubilized GABA recognition sites from heat inactivation. These results indicate that the protection exerted by benzodiazepines against the heat inactivation of GABA recognition sites is mediated by the binding of benzodiazepines to specific recognition sites.
It is interesting that the procedure adopted for the solubilization of ["HIGABA binding sites solubilizes a very small percentage (8%) of the total ["Hlbenzodiazepine binding proteins (see Table VI ). Since this extraction was carried out at 0 to 2"C, comparison of the data of Tables III and VI suggests that the solubilization of the [3H]benzodiazepine binding sites elicited by Triton X-100 is a temperature-dependent process.
Several reports on the solubilized binding sites of ["HIGABA or ["Hlbenzodiazepines fail to take into consideration that the process requires the removal of endogenous modulators or ligands for these recognition sites. Because we considered this possibility as a critical point, our purification procedure includes as a last step a procedure to free the solubilized recognition sites from endogenous materials (modulator peptides, amino acids, ions) that might interfere with the binding assay. This was achieved by using the minicolumn gel filtration procedure described by Penefsky (1977) . With this gel filtration technique, it was possible to remove effectively the endogenous GABA from the solubilized recognition sites even when the starting material was fresh brain cortex homogenate. In addition, since this filtration technique is rapid, the degradation of the recognition sites during this purification step is minimal. Solubilization, purification, and subsequent recombination of GABA and benzodiazepine recognition sites with purified modulatory factors extracted from brain membranes has been the final goal of our present research. We have reported in the past that it is possible to extract from CSM a material (GABA-modulin) that inhibits ["HIGABA and [3H] benzodiazepine binding to CSM (Guidotti et al., 1978) . The present experiments shed new light, suggesting that the inhibitor of GABA binding (GABA-modulin) is different from the compound that displaces ["Hldiazepam from its high affinity binding sites. Table I shows that the characteristics of the two modulators are different. In particular, GABA-modulin is relatively thermolabile, while the inhibitor of ["Hlbenzodiazepine binding is highly thermoresistant. Thus, by using a thermoinactivation procedure (see "Materials and Methods") and different column chromatography techniques, it has been possible to separate GABA-modulin from the inhibitor of ["Hlbenzodiazepine binding.
In addition to GABA-modulin, other endogenous compounds, such as GABA (Napias et al., 1980), phospholipids (Johnston and Kennedy, 1978; Lloyd and Davidson, 1979) , and a number of small molecular weight materials (Yoneda and Kuriyama, 1980; Mazzari et al., 1980) , interfere with the high affinity [3H]GABA binding. We have sought, therefore, to establish whether, in our GABA-modulin preparation, sufficient quantities of GABA and phospholipids were present to inhibit the high affinity binding. The data summarized in Table I , indicate that a contamination by GABA is unlikely to play a role in the inhibition of high affinity GABA binding
